|
[1] MIELI-VERGANI G,VERGANI D,CZAJA AJ,et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers,2018,4:18017.
|
|
[2] ALVAREZ F,BERG PA,BIANCHI FB,et al. International Autoimmune Hepatitis Group Report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.
|
|
[3] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.
|
|
[4] WANG Q,YANG F,MIAO Q,et al. The clinical phenotypes of autoimmune hepatitis:A comprehensive review[J]. J Autoimmun,2016,66:98-107.
|
|
[5] WANG QX,YAN L,MA X. Autoimmune hepatitis in the AsiaPacific area[J]. J Clin Transl Hepatol,2018,6(1):48-56.
|
|
[6] MACK CL,ADAMS D,ASSIS DN,et al. Diagnosis and management of autoimmune hepatitis in adults and children:2019practice guidance and guidelines from the American Association for the Study of Liver Diseases[J]. Hepatology,2019.[Epub ahead of print]
|
|
[7] TANG R,WEI Y,LI Y,et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy[J]. Gut,2018,67(3):534-541.
|
|
[8] MANFREDO VIEIRA S,HILTENSPERGER M,KUMAR V,et al.Translocation of a gut pathobiont drives autoimmunity in mice and humans[J]. Science,2018,359(6380):1156-1161.
|
|
[9] WEI Y,LI Y,YAN L,et al. Alterations of gut microbiome in autoimmune hepatitis[J]. Gut,2020,69(3):569-577.
|
|
[10] VIGNALI DA,KUCHROO VK. IL-12 family cytokines:Immunological playmakers[J]. Nat Immunol,2012,13(8):722-728.
|
|
[11] LIAN M,ZHANG J,ZHAO L,et al. Interleukin-35 regulates immune microenvironment of autoimmune hepatitis through inducing the expansion of myeloid-derived suppressor cells[J]. Front Immunol,2019,10:2577.
|
|
[12] RAHIM MN,LIBERAL R,MIQUEL R,et al. Acute severe autoimmune hepatitis:Corticosteroids or liver transplantation?[J]. Liver Transpl,2019,25(6):946-959.
|
|
[13] ANAND L,CHOUDHURY A,BIHARI C,et al. Flare of autoimmune hepatitis causing acute on chronic liver failure:Diagnosis and response to corticosteroid therapy[J]. Hepatology,2019,70(2):587-596.
|
|
[14] SARIN SK,CHOUDHURY A,SHARMA MK,et al. Correction to:Acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL):An update[J]. Hepatol Int,2019,13(6):826-828.
|
|
[15] PEISELER M,LIEBSCHER T,SEBODE M,et al. Efficacy and limitations of budesonide as a second-line treatment for patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2018,16(2):260-267. e1.
|
|
[16] van den BRAND FF,van der VEEN KS,LISSENBERG-WITTE BI,et al. Adverse events related to low dose corticosteroids in autoimmune hepatitis[J]. Aliment Pharmacol Ther,2019,50(10):1120-1126.
|
|
[17] SCHMIDT T,SCHMIDT C,STRAHL A,et al. A system to determine risk of osteoporosis in patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2020,18(1):226-233. e3.
|
|
[18] PAPE S,GEVERS T,VROLIJK JM,et al. Rapid response to treatment of autoimmune hepatitis associated with remission at6 and 12 months[J]. Clin Gastroenterol Hepatol,2019.[Epub ahead of print]
|
|
[19] WANG Q,QIU D,MA X. Early normalisation of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients[J]. Aliment Pharmacol Ther,2011,34(1):107-109.
|
|
[20] TANSEL A,KATZ LH,EL-SERAG HB,et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis:A systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol,2017,15(8):1207-1217. e4.
|
|
[21] van den BRAND FF,van der VEEN KS,de BOER YS,et al.Increased mortality among patients with vs without cirrhosis and autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2019,17(5):940-947. e2.
|
|
[22] CHEN RL,WANG QX,MA X. Precision medicine for autoimmune hepatitis[J]. J Dig Dis,2019,20(7):331-337.
|
DownLoad: